tiprankstipranks
Advertisement
Advertisement

TTRX Stock Latest News

Turn Therapeutics announces publication of peer-reviewed research on GX-03
The FlyTurn Therapeutics announces publication of peer-reviewed research on GX-03
5d ago
TTRX
Turn Therapeutics Reports Unregistered Cashless Warrant Share Issuance
PremiumCompany Announcements
Turn Therapeutics Reports Unregistered Cashless Warrant Share Issuance
7d ago
8K
TTRX
Turn Therapeutics Raises $1.35M Through Private Placement
PremiumCompany Announcements
Turn Therapeutics Raises $1.35M Through Private Placement
7d ago
8K
TTRX
Turn Therapeutics reports Q2 EPS (20c) vs (5c) last year
PremiumThe Fly
Turn Therapeutics reports Q2 EPS (20c) vs (5c) last year
8d ago
TTRX
Turn Therapeutics Updates GX-03 Investor Presentation and Pipeline
PremiumCompany Announcements
Turn Therapeutics Updates GX-03 Investor Presentation and Pipeline
28d ago
8K
TTRX
PremiumCompany AnnouncementsTurn Therapeutics advances GX-03 Phase 2 eczema program
2M ago
8K
TTRX
Turn Therapeutics announces final Stage 2 design of atopic dermatitis program
Premium
The Fly
Turn Therapeutics announces final Stage 2 design of atopic dermatitis program
2M ago
TTRX
Turn Therapeutics Highlights GX-03 Phase 2 Atopic Dermatitis Data
Premium
Company Announcements
Turn Therapeutics Highlights GX-03 Phase 2 Atopic Dermatitis Data
3M ago
8K
TTRX
Turn announces interim analysis findings from Phase 2 trial of GX-03
PremiumThe Fly
Turn announces interim analysis findings from Phase 2 trial of GX-03
3M ago
TTRX
Turn Therapeutics Reports Positive Interim Phase 2 GX-03 Data
PremiumCompany Announcements
Turn Therapeutics Reports Positive Interim Phase 2 GX-03 Data
3M ago
8K
TTRX
Turn Therapeutics announces peer-reviewed article on GX-03
PremiumThe Fly
Turn Therapeutics announces peer-reviewed article on GX-03
3M ago
TTRX
Turn Therapeutics highlights GX-03 preclinical data in dermatitis
PremiumCompany Announcements
Turn Therapeutics highlights GX-03 preclinical data in dermatitis
3M ago
8K
TTRX
Turn Therapeutics CEO to Present at Jefferies Conference
PremiumCompany AnnouncementsTurn Therapeutics CEO to Present at Jefferies Conference
3M ago
8K
TTRX
Turn Therapeutics Appoints Former FDA Chief to Lead GX-03
Premium
Company Announcements
Turn Therapeutics Appoints Former FDA Chief to Lead GX-03
3M ago
8K
TTRX
Turn appoints Hahn as Executive Clinical, Regulatory Lead for GX-03
Premium
The Fly
Turn appoints Hahn as Executive Clinical, Regulatory Lead for GX-03
3M ago
TTRX
Turn Therapeutics reports Q1 EPS (3c) vs. (1c) last year
PremiumThe Fly
Turn Therapeutics reports Q1 EPS (3c) vs. (1c) last year
4M ago
TTRX
Turn Therapeutics reports FY25 EPS (12c) vs. (7c) last year
PremiumThe Fly
Turn Therapeutics reports FY25 EPS (12c) vs. (7c) last year
5M ago
TTRX
Turn Therapeutics Secures Growth Capital to Advance Dermatology
PremiumCompany Announcements
Turn Therapeutics Secures Growth Capital to Advance Dermatology
5M ago
8K
TTRX
Turn Therapeutics secures up to $25M in financing
PremiumThe Fly
Turn Therapeutics secures up to $25M in financing
5M ago
TTRX
Turn Therapeutics Appoints Robert Redfield as Senior Advisor
PremiumCompany AnnouncementsTurn Therapeutics Appoints Robert Redfield as Senior Advisor
6M ago
8K
TTRX
Turn Therapeutics Highlights GX-03 Progress at Investor Conferences
Premium
Company Announcements
Turn Therapeutics Highlights GX-03 Progress at Investor Conferences
7M ago
8K
TTRX
Turn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
Premium
Company Announcements
Turn Therapeutics Advances GX-03 Eczema Trial, Opening a New Catalyst for Investors
7M ago
TTRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >